GlassScriptPhysician profile
Scarlett Wade
NPI 1013387331
$1,729.26
in general payments reported to CMS, 2019-2025
23 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $726 · 2022: $194 · 2023: $472 · 2024: $192 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $631.50 | 2021-2024 | |
| Novo Nordisk INC | $185.95 | 2021-2025 | Wegovy |
| Astellas Pharma US INC | $138.02 | 2021-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $118.71 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $83.87 | 2021 | |
| Mayne Pharma Commercial LLC | $77.44 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $69.32 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $68.21 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $52.51 | 2024-2025 | |
| Organon LLC | $39.83 | 2021-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $35.17 | 2021-2022 | |
| Corium, LLC | $27.13 | 2023 | Azstarys |
| Exeltis, USA INC. | $24.82 | 2022 | |
| Biogen, INC. | $23.83 | 2025 | Zurzuvae |
| Pacira Pharmaceuticals Incorporated | $22.56 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $22.40 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $19.09 | 2022 | |
| Boston Scientific Corporation | $17.63 | 2022 | |
| Evofem Biosciences, INC. | $15.43 | 2021 | |
| Urovant Sciences INC | $15.08 | 2022 | |
| Lilly USA, LLC | $13.99 | 2024 | Zepbound |
| Dysis Medical, INC. | $13.84 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scarlett Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.